These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36072656)

  • 21. The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma.
    Li YJ; Li HY; Zhang Q; Wei SL
    Front Genet; 2022; 13():942785. PubMed ID: 35942287
    [No Abstract]   [Full Text] [Related]  

  • 22. The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma.
    Sun P; Xu H; Zhu K; Li M; Han R; Shen J; Xia X; Chen X; Fei G; Zhou S; Wang R
    Front Genet; 2022; 13():1061382. PubMed ID: 36531222
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature.
    Liu G; Li F; Ge Y; Shi Y; Ren F; Zhu L
    J Cancer; 2023; 14(17):3335-3350. PubMed ID: 37928426
    [No Abstract]   [Full Text] [Related]  

  • 24. Predicting prognosis, immunotherapy and distinguishing cold and hot tumors in clear cell renal cell carcinoma based on anoikis-related lncRNAs.
    Hao C; Li R; Lu Z; He K; Shen J; Wang T; Qiu T
    Front Immunol; 2023; 14():1145450. PubMed ID: 37359524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma.
    Zhou Y; Shu Q; Fu Z; Wang C; Gu J; Li J; Chen Y; Xie M
    Front Genet; 2022; 13():959456. PubMed ID: 35938036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer.
    Wang Q; Xu Y
    Front Pharmacol; 2022; 13():1065701. PubMed ID: 36532719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cuproptosis in ccRCC: key player in therapeutic and prognostic targets.
    Lv Y; Li Q; Yin L; He S; Qin C; Lu Z; Chen H
    Front Oncol; 2023; 13():1271864. PubMed ID: 37965478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a risk model and prediction of prognosis and immunotherapy based on cuproptosis-related LncRNAs in the urinary system pan-cancer.
    Ma Z; Liang H; Cui R; Ji J; Liu H; Liu X; Shen P; Wang H; Wang X; Song Z; Jiang Y
    Eur J Med Res; 2023 Jun; 28(1):198. PubMed ID: 37370148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma.
    Mo X; Hu D; Yang P; Li Y; Bashir S; Nai A; Ma F; Jia G; Xu M
    Front Oncol; 2022; 12():927706. PubMed ID: 35936736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct tumor microenvironment landscapes in gastric cancer classified by cuproptosis-related lncRNAs.
    Huang J; Chen M; Pei W; Xu Z; Ning J; Chen C
    J Cancer; 2022; 13(15):3687-3700. PubMed ID: 36606199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
    Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
    J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma.
    Xie T; Liu B; Liu D; Zhou Y; Yang Q; Wang D; Tang M; Liu W
    Front Pharmacol; 2022; 13():1103986. PubMed ID: 36618928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma.
    Yu W; Huo H; You Z; Lu R; Yao T; Huang J
    Front Genet; 2022; 13():982888. PubMed ID: 36160008
    [No Abstract]   [Full Text] [Related]  

  • 36. Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma.
    Yang X; Wang X; Sun X; Xiao M; Fan L; Su Y; Xue L; Luo S; Hou S; Wang H
    Front Genet; 2022; 13():972899. PubMed ID: 36160015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer.
    Liu L; Zheng J; Xia H; Wu Q; Cai X; Ji L; Sun Y
    Front Genet; 2023; 14():1023613. PubMed ID: 36777734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator
    Zeng S; Zhang H; Zhang D; Hu X; Song L
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of cuproptosis-related long noncoding RNA immune infiltration and prediction of prognosis in patients with bladder cancer.
    Zhang Y; Li X; Li X; Zhao Y; Zhou T; Jiang X; Wen Y; Meng W; Li S
    Front Genet; 2022; 13():990326. PubMed ID: 36186475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.